Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LOARGYS (pegzilarginase-nbln) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-3058

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LOARGYS (pegzilarginase-nbln)

Documents

Comments

Description

OPEN

Comment Period OpensApr 7, 2026

Type	Title	Posted	Comments	Status
Notice	Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LOARGYS (pegzilarginase-nbln) FR Doc: 2026-06722	Apr 7, 2026	--

CDER

2026-166

Notice

Issuance of Priority Review Voucher

Rare Pediatric Disease Product

LOARGYS (pegzilarginase-nbln)

OPEN